UA77229U - Method for determination of sterile women to be stimulated for ovulation with clomiphene citrate - Google Patents

Method for determination of sterile women to be stimulated for ovulation with clomiphene citrate

Info

Publication number
UA77229U
UA77229U UAU201207368U UAU201207368U UA77229U UA 77229 U UA77229 U UA 77229U UA U201207368 U UAU201207368 U UA U201207368U UA U201207368 U UAU201207368 U UA U201207368U UA 77229 U UA77229 U UA 77229U
Authority
UA
Ukraine
Prior art keywords
ovulation
stimulated
determination
clomiphene citrate
level
Prior art date
Application number
UAU201207368U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Тетяна Леонидівна Архипкіна
Лідія Павлівна Любимова
Володимир Олександрович Бондаренко
Юрій Іванович Караченцев
Original Assignee
Государственное Учреждение "Институт Проблем Эндокринной Патологии Им. В.Я. Данилевского Национальной Академии Медицинских Наук Украины"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Институт Проблем Эндокринной Патологии Им. В.Я. Данилевского Национальной Академии Медицинских Наук Украины" filed Critical Государственное Учреждение "Институт Проблем Эндокринной Патологии Им. В.Я. Данилевского Национальной Академии Медицинских Наук Украины"
Priority to UAU201207368U priority Critical patent/UA77229U/en
Publication of UA77229U publication Critical patent/UA77229U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Disclosed is a method for determination of sterile women to be stimulated for ovulation with clomiphene citrate through measurement of the level of antimuller hormone. Therapy with combined oral contraceptives is carried out in sterile women suffering on polycystic ovarian syndrome, at that the level of antimuller hormone in blood serum is investigated, and if its basal level is not more than 10.3 ng/ml, and in 6 months from beginning of treatment this index is decreased not less than by 50 %, stimulation of ovulation with clomiphene citrate is performed.
UAU201207368U 2012-06-18 2012-06-18 Method for determination of sterile women to be stimulated for ovulation with clomiphene citrate UA77229U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201207368U UA77229U (en) 2012-06-18 2012-06-18 Method for determination of sterile women to be stimulated for ovulation with clomiphene citrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201207368U UA77229U (en) 2012-06-18 2012-06-18 Method for determination of sterile women to be stimulated for ovulation with clomiphene citrate

Publications (1)

Publication Number Publication Date
UA77229U true UA77229U (en) 2013-02-11

Family

ID=51586845

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201207368U UA77229U (en) 2012-06-18 2012-06-18 Method for determination of sterile women to be stimulated for ovulation with clomiphene citrate

Country Status (1)

Country Link
UA (1) UA77229U (en)

Similar Documents

Publication Publication Date Title
MX354371B (en) Dosage regimen for administering a cd19xcd3 bispecific antibody to patients at risk for potential adverse effects.
NZ598732A (en) Dosage regimen for administering a cd19xcd3 bispecific antibody
NZ609201A (en) Means and methods for treating dlbcl
MX355611B (en) High-concentration monoclonal antibody formulations.
UA124238U (en) METHOD OF TREATMENT OF BREAST CANCER
IN2012DN03172A (en)
SG10201906172XA (en) Regulation of glucose metabolism using anti-cgrp antibodies
NZ754328A (en) Marker for acid sphingomyelinase disorders and uses thereof
WO2012063134A3 (en) Cardiac glycoside analogs in combination with emodin for cancer therapy
EA201691420A1 (en) COMPOSITIONS OF ENOLOGY 1 (ENO1) AND THEIR APPLICATION
NZ720273A (en) Preparations and methods for treating a gd2 positive cancer
MX2021015228A (en) Methods and compositions for improving outcomes of cancer patients.
UA77229U (en) Method for determination of sterile women to be stimulated for ovulation with clomiphene citrate
Klein Facial palsy and retinal vein occlusion: 3 case reports
NZ705229A (en) Pharmaceutical formulations containing ipidacrine and their use for the treatment of disorders of potency and disorders of other forms of sexual activity
MX2022002947A (en) Avocatin b for the treatment of diseases and conditions.
PL425544A1 (en) Immunomodulation of cells from myeloid lineage as a therapy
Navarro Gracia Calcium carbimide
McMillen Ipilimumab/nivolumab
UA117206U (en) METHOD OF TREATMENT OF FRUIT DISTRESS IN PREGNANT PREGNANCY
Saito Valproic acid/levocarnitine
Mahoney Doxorubicin liposomal
Hohmeier Post-herpetic neuralgia: case report
Cevher Skin rash: case report
Nishino Ipilimumab/nivolumab